Sudeep Pharma IPO: 10 key points to consider before ₹895 crore offer opening

Sudeep Pharma IPO: The initial public offering of Sudeep Pharma will open for subscription on Friday, November 21. The issue will conclude on November 25. The bidding for anchor investors will take place on November 20.

As the IPO is just around the corner, here are key things to know.

Sudeep Pharma IPO: 10 key points to know

• Sudeep Pharma IPO subscription period: The initial public offering will be live from Friday, November 21, to Tuesday, November 25.
• IPO offer structure: The ₹895 crore IPO is a mix of fresh issuance of shares totalling ₹95 crore and an offer for sale (OFS) of 1.35 crore shares aggregating to ₹800 crore.
• Objectives: Under the OFS, promoters Sujit Jaysukh Bhayani, Avani Sujit Bhayani, Shanil Sujit Bhayani and Sujeet Jaysukh Bhayani HUF would divest their stake. The fresh issue proceeds will be utilised for the procurement of machinery and corporate general purposes.
• Sudeep Pharma IPO price band: The price range has been fixed at ₹563 to ₹593 per equity share.
• Reservation: The company has set aside 50% of the net offer for qualified institutional buyers, 15% for non-institutional investors (NIIs) and 35% for retail investors.
• Sudeep Pharma IPO lot size: Retail investors can apply for a minimum of 25 shares and in multiples thereafter.
• Book-running lead managers: ICICI Securities and IIFL Capital Services are the IPO's book-running lead managers.
• Registrar: MUFG Intime India Pvt Ltd is the registrar.
• Sudeep Pharma IPO allotment date: The allotment is likely to be finalised on November 26.
• Listing date: The listing on the BSE and the NSE will take place on November 28.

Sudeep Pharma IPO GMP

According to media reports and investorgain.com, unlisted shares of Sudeep Pharma are trading at ₹728, reflecting a grey market premium of 22.77% over the upper price band of ₹593.